The development and validation of biomarkers involve several stages. Initially, potential biomarkers are identified through research studies that explore the biological effects of toxicants. Once identified, biomarkers undergo rigorous validation processes to confirm their specificity, sensitivity, and reliability. This often involves extensive laboratory testing and clinical trials to ensure that the biomarker accurately reflects the exposure or effect it is intended to measure.
